Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elan Says It Has Fixed The Biogen Breach, And Gives J&J a $115 Million Discount

This article was originally published in The Pink Sheet Daily

Executive Summary

The three-way drama heads toward a resolution -- if Biogen Idec accepts Elan's moves.
Advertisement

Related Content

Rich Enough to Reduce Debt, Elan Again Pulls Drug-Delivery Unit Off the Block
Rich Enough to Reduce Debt, Elan Again Pulls Drug-Delivery Unit Off the Block
J&J Braces For Health Care Reform Hit, But Can "Accommodate" Impact
J&J Braces For Health Care Reform Hit, But Can "Accommodate" Impact
SEC Investigates Elan Over Disclosures of Clinical Trial Data and Side Effect Reports
Elan Moves Ahead With J&J Deal, But Does Biogen Really Approve?
Judge Says Elan's J&J Deal Violates Tysabri Contract, Handing Biogen A Victory
A Safety Net That May Not Be So Safe: Elan Sues Biogen Over J&J Deal
A Safety Net That May Not Be So Safe: Elan Sues Biogen Over J&J Deal
J&J And Elan Strike A Deal On Key Alzheimer's Disease Assets

Topics

Advertisement
UsernamePublicRestriction

Register

PS069962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel